{"id":"https://openalex.org/W2228799646","doi":"https://doi.org/10.3109/1061186x.2015.1132223","title":"Enhanced delivery of etoposide across the blood\u2013brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles","display_name":"Enhanced delivery of etoposide across the blood\u2013brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles","alternate_titles":[],"publication_year":2016,"publication_date":"2016-01-15","ids":{"openalex":"https://openalex.org/W2228799646","doi":"https://doi.org/10.3109/1061186x.2015.1132223","mag":"2228799646","pmid":"https://pubmed.ncbi.nlm.nih.gov/26768307"},"language":"en","primary_location":{"id":"doi:10.3109/1061186x.2015.1132223","doi":"https://doi.org/10.3109/1061186x.2015.1132223","is_oa":false,"landing_page_url":"https://doi.org/10.3109/1061186x.2015.1132223","pdf_url":null,"source":{"id":"https://openalex.org/S100629371","display_name":"Journal of drug targeting","issn_l":"1026-7158","issn":["1026-7158","1029-2330","1061-186X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Targeting","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2228799646"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063177635","display_name":"Yung\u2010Chih Kuo","orcid":"https://orcid.org/0000-0002-5837-8546","observed_orcids":["https://orcid.org/0000-0002-5837-8546"]},"institutions":[{"id":"https://openalex.org/I148099254","display_name":"National Chung Cheng University","ror":"https://ror.org/0028v3876","country_code":"TW","type":"education","lineage":["https://openalex.org/I148099254"]}],"countries":["TW"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yung-Chih Kuo","raw_affiliation_strings":["Department of Chemical Engineering, National Chung Cheng University, Chia-Yi, Taiwan, Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Engineering, National Chung Cheng University, Chia-Yi, Taiwan, Republic of China","institution_ids":["https://openalex.org/I148099254"]}]},{"author_position":"last","author":{"id":null,"display_name":"I-Hsin Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I148099254","display_name":"National Chung Cheng University","ror":"https://ror.org/0028v3876","country_code":"TW","type":"education","lineage":["https://openalex.org/I148099254"]}],"countries":["TW"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I-Hsin Wang","raw_affiliation_strings":["Department of Chemical Engineering, National Chung Cheng University, Chia-Yi, Taiwan, Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Engineering, National Chung Cheng University, Chia-Yi, Taiwan, Republic of China","institution_ids":["https://openalex.org/I148099254"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5063177635"],"corresponding_institution_ids":["https://openalex.org/I148099254"],"apc_list":null,"apc_paid":null,"fwci":2.1464,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.85443808,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"24","issue":"7","first_page":"645","last_page":"654"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.047600001096725464,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9890000224113464},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.8569999933242798},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9380000233650208},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.9620000123977661},{"id":"https://openalex.org/keywords/solid-lipid-nanoparticles","display_name":"solid lipid nanoparticles","score":0.9860000014305115},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.6259999871253967},{"id":"https://openalex.org/keywords/blood-brain-barrier-permeability","display_name":"blood-brain barrier permeability","score":0.8450000286102295},{"id":"https://openalex.org/keywords/brain-tumor-drug-delivery","display_name":"brain tumor drug delivery","score":0.734000027179718},{"id":"https://openalex.org/keywords/u87-cells","display_name":"U87 cells","score":0.8119999766349792},{"id":"https://openalex.org/keywords/brain-microvascular-endothelial-cells","display_name":"brain microvascular endothelial cells","score":0.8529999852180481},{"id":"https://openalex.org/keywords/nanoparticle-uptake","display_name":"nanoparticle uptake","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C199529486","wikidata":"https://www.wikidata.org/wiki/Q7557912","display_name":"Solid lipid nanoparticle","level":3,"score":0.8825247287750244},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.6827214360237122},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45519009232521057},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44437238574028015},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.4139323830604553},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25824618339538574},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1506258249282837},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.12220758199691772},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.11032286286354065},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08751022815704346}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3109/1061186x.2015.1132223","doi":"https://doi.org/10.3109/1061186x.2015.1132223","is_oa":false,"landing_page_url":"https://doi.org/10.3109/1061186x.2015.1132223","pdf_url":null,"source":{"id":"https://openalex.org/S100629371","display_name":"Journal of drug targeting","issn_l":"1026-7158","issn":["1026-7158","1029-2330","1061-186X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Targeting","raw_type":"journal-article"},{"id":"pmid:26768307","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26768307","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drug targeting","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W113910550","https://openalex.org/W197014098","https://openalex.org/W1574424832","https://openalex.org/W1579046626","https://openalex.org/W1966593985","https://openalex.org/W1978208782","https://openalex.org/W1981956388","https://openalex.org/W1992854414","https://openalex.org/W2008597360","https://openalex.org/W2010604263","https://openalex.org/W2014537537","https://openalex.org/W2020216724","https://openalex.org/W2021213789","https://openalex.org/W2022261342","https://openalex.org/W2025418692","https://openalex.org/W2025525510","https://openalex.org/W2025624736","https://openalex.org/W2030009196","https://openalex.org/W2031892070","https://openalex.org/W2035703861","https://openalex.org/W2044681516","https://openalex.org/W2049634070","https://openalex.org/W2052640429","https://openalex.org/W2055233461","https://openalex.org/W2055449190","https://openalex.org/W2057460376","https://openalex.org/W2059699128","https://openalex.org/W2062788796","https://openalex.org/W2068722147","https://openalex.org/W2072273122","https://openalex.org/W2078109197","https://openalex.org/W2078458130","https://openalex.org/W2080425462","https://openalex.org/W2083230753","https://openalex.org/W2088748784","https://openalex.org/W2093004080","https://openalex.org/W2101099825","https://openalex.org/W2106385327","https://openalex.org/W2117691576","https://openalex.org/W2121242907","https://openalex.org/W2138053088","https://openalex.org/W2151317721","https://openalex.org/W2154851272","https://openalex.org/W2163695841","https://openalex.org/W2164049072","https://openalex.org/W2165574853","https://openalex.org/W2166440745","https://openalex.org/W2168843129","https://openalex.org/W2171258274","https://openalex.org/W2248363016","https://openalex.org/W2423489009","https://openalex.org/W4244342114"],"related_works":["https://openalex.org/W2266347643","https://openalex.org/W2525816288","https://openalex.org/W2277529550","https://openalex.org/W2071687560","https://openalex.org/W1983800816","https://openalex.org/W2211734418","https://openalex.org/W2616785426","https://openalex.org/W2025525510","https://openalex.org/W2285716892","https://openalex.org/W2619728645"],"abstract_inverted_index":{"Melanotransferrin":[0],"antibody":[1],"(MA)":[2],"and":[3,21,26,47,67,133],"tamoxifen":[4],"(TX)":[5],"were":[6,30],"conjugated":[7],"on":[8],"etoposide":[9],"(ETP)-entrapped":[10],"solid":[11],"lipid":[12],"nanoparticles":[13],"(ETP-SLNs)":[14],"to":[15,32,48,130,152,158],"target":[16,131],"the":[17,34,50,61,69,84,107,116,156],"blood-brain":[18],"barrier":[19],"(BBB)":[20],"glioblastom":[22],"multiforme":[23],"(GBM).":[24],"MA-":[25],"TX-conjugated":[27],"ETP-SLNs":[28,57,123],"(MA-TX-ETP-SLNs)":[29],"used":[31],"infiltrate":[33],"BBB":[35,62,85,157],"comprising":[36],"a":[37,101,149],"monolayer":[38],"of":[39,52,72,94,104,118,128,143],"human":[40,42],"astrocyte-regulated":[41],"brain-microvascular":[43],"endothelial":[44],"cells":[45,113,135],"(HBMECs)":[46],"restrain":[49],"proliferation":[51],"malignant":[53],"U87MG":[54,112,134],"cells.":[55],"TX-grafted":[56],"(TX-ETP-SLNs)":[58],"significantly":[59],"enhanced":[60],"permeability":[63,86],"coefficient":[64,87],"for":[65,88],"ETP":[66,89,154],"raised":[68],"fluorescent":[70],"intensity":[71],"calcein-AM":[73],"when":[74],"compared":[75],"with":[76],"ETP-SLNs.":[77],"In":[78],"addition,":[79],"surface":[80],"MA":[81],"could":[82],"increase":[83],"about":[90],"twofold.":[91],"The":[92,126],"viability":[93],"HBMECs":[95,132],"was":[96,114,138],"higher":[97],"than":[98],"86%,":[99],"suggesting":[100],"high":[102],"biocompatibility":[103],"MA-TX-ETP-SLNs.":[105],"Moreover,":[106],"efficiency":[108],"in":[109,115],"antiproliferation":[110],"against":[111],"order":[117],"MA-TX-ETP-SLNs":[119,129,146],">":[120,122,124],"TX-ETP-SLNs":[121],"SLNs.":[125],"capability":[127],"during":[136],"internalization":[137],"verified":[139],"by":[140],"immunochemical":[141],"staining":[142],"expressed":[144],"melanotransferrin.":[145],"can":[147],"be":[148],"potent":[150],"pharmacotherapy":[151],"deliver":[153],"across":[155],"GBM.":[159]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2228799646","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
